Details

---

Manufacturer
NOVARTIS PHARMA STEIN A.G.(SWITZERLAND)
Registraction Number
MAL24016005ARZ

Contents

Active Ingredient: Trametinib, 0.5 mg per tablet.
Excipients: Includes mannitol, microcrystalline cellulose, hypromellose, croscarmellose sodium, magnesium stearate, and others.

Indications

Meqsel is used for:
Treatment of unresectable or metastatic melanoma with a BRAF V600 mutation.
Advanced non-small cell lung cancer (NSCLC) with a BRAF V600 mutation.
Combination therapy with dabrafenib for enhanced effectiveness in certain cancers.

Instructions

Dosage: Typically, 2 mg orally once daily, as prescribed by a healthcare professional.
Administration: Take on an empty stomach, at least 1 hour before or 2 hours after a meal.
Precautions:
Regular monitoring of liver function, vision, and heart health is recommended.
Avoid use during pregnancy or breastfeeding.
Inform your doctor about any other medications or health conditions.
Storage: Store in a refrigerator (2–8°C). Do not freeze.